Non-neovascular age-related macular degeneration with subretinal fluid.


Journal

The British journal of ophthalmology
ISSN: 1468-2079
Titre abrégé: Br J Ophthalmol
Pays: England
ID NLM: 0421041

Informations de publication

Date de publication:
10 2021
Historique:
received: 25 06 2020
accepted: 13 08 2020
revised: 05 08 2020
pubmed: 14 9 2020
medline: 3 3 2022
entrez: 13 9 2020
Statut: ppublish

Résumé

To evaluate the various patterns of subretinal fluid (SRF) in eyes with age-related macular degeneration (AMD) in the absence of macular neovascularisation (MNV) and to assess the long-term outcomes in these eyes. This retrospective study included only eyes with non-neovascular AMD and associated SRF. Eyes with evidence of MNV were excluded. Spectral-domain optical coherence tomography (SD-OCT) was obtained at baseline and at follow-up, and qualitative and quantitative SD-OCT analysis of macular drusen including drusenoid pigment epithelial detachment (PED) and associated SRF was performed to determine anatomic outcomes. Forty-five eyes (45 patients) were included in this analysis. Mean duration of follow-up was 49.7±36.7 months. SRF exhibited three different morphologies: crest of fluid over the apex of the drusenoid PED, pocket of fluid at the angle of a large druse or in the crypt of confluent drusen or drape of low-lying fluid over confluent drusen. Twenty-seven (60%) of the 45 eyes with fluid displayed collapse of the associated druse or drusenoid PED and 24 (53%) of the 45 eyes developed evidence of complete or incomplete retinal pigment epithelial and outer retinal atrophy. Non-neovascular AMD with SRF is an important clinical entity to recognise to avoid unnecessary anti-vascular endothelial growth factor therapy. Clinicians should be aware that SRF can be associated with drusen or drusenoid PED in the absence of MNV and may be the result of retinal pigment epithelial (RPE) decompensation and RPE pump failure.

Identifiants

pubmed: 32920528
pii: bjophthalmol-2020-317326
doi: 10.1136/bjophthalmol-2020-317326
doi:

Substances chimiques

Angiogenesis Inhibitors 0
Retinal Pigments 0
Vascular Endothelial Growth Factor A 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1415-1420

Informations de copyright

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Assaf Hilely (A)

Division of Ophthalmology, Tel Aviv Ichilov-Sourasky Medical Center, Tel Aviv, Israel.

Adrian Au (A)

Retinal Disorders and Ophthalmic Genetics Division, Stein Eye Institute, University of California, Los Angeles, Los Angeles, California, USA.

K Bailey Freund (KB)

Vitreous Retina Macula Consultants of New York, New York, New York, USA.

Anat Loewenstein (A)

Division of Ophthalmology, Tel Aviv Ichilov-Sourasky Medical Center, Tel Aviv, Israel.

Eric H Souied (EH)

Ophthalmology, Centre Hospitalier Intercommunal De Creteil, Creteil, France.

Dinah Zur (D)

Division of Ophthalmology, Tel Aviv Ichilov-Sourasky Medical Center, Tel Aviv, Israel.

Riccardo Sacconi (R)

Ophthalmology, Ospedale San Raffaele, Milano, Italy.

Enrico Borrelli (E)

Ophthalmology, Ospedale San Raffaele, Milano, Italy.

Enrico Peiretti (E)

Department of Surgical Sciences, Eye Clinic, University of Cagliari, Cagliari, Italy.

Claudio Iovino (C)

Department of Surgical Sciences, Eye Clinic, University of Cagliari, Cagliari, Italy.

Yoshimi Sugiura (Y)

Department of Ophthalmology, University of Tsukuba Faculty of Medicine, Tsukuba, Japan.

Abdallah A Ellabban (AA)

Hull University Teaching Hospitals NHS Trust, Hull, UK.
Suez Canal University Faculty of Medicine, Ismailia, Egypt.

Jordi Monés (J)

Barcelona Macula Foundation, Barcelona, Spain.

Nadia K Waheed (NK)

New England Eye Center, Tufts University School of Medicine, Boston, Massachusetts, USA.

Sengul Ozdek (S)

Department of Ophthalmology, Gazi University, School of Medicine, Ankara, Turkey.

Duygu Yalinbas (D)

Department of Ophthalmology, Gazi University, School of Medicine, Ankara, Turkey.

Sarah Thiele (S)

Ophthalmology, University of Bonn, Bonn, Germany.

Luísa Salles de Moura Mendonça (LS)

New England Eye Center, Tufts University School of Medicine, Boston, Massachusetts, USA.

Mee Yon Lee (MY)

Catholic University of Korea College of Medicine, Seoul, South Korea.

Won Ki Lee (WK)

Nune Eye Hospital, Seoul, South Korea.

Pierre Turcotte (P)

Private practice, Quebec City, Canada.

Vittorio Capuano (V)

Ophthalmology, Centre Hospitalier Intercommunal De Creteil, Creteil, France.

Meryem Filali Ansary (M)

Ophthalmology, Centre Hospitalier Intercommunal De Creteil, Creteil, France.

Usha Chakravarthy (U)

Department of Ophthalmology, Queen's University of Belfast, Belfast, UK.

Albrecht Lommatzsch (A)

Department of Ophthalmology, Sankt Franziskus-Hospital Münster GmbH, Munster, Germany.

Frederic Gunnemann (F)

Department of Ophthalmology, Sankt Franziskus-Hospital Münster GmbH, Munster, Germany.

Daniel Pauleikhoff (D)

Department of Ophthalmology, Sankt Franziskus-Hospital Münster GmbH, Munster, Germany.

Michael S Ip (MS)

Doheny Image Reading Center, Doheny Eye Institute, Los Angeles, California, USA.

Giuseppe Querques (G)

Ophthalmology, Ospedale San Raffaele, Milano, Italy.

Frank G Holz (FG)

Ophthalmology, University of Bonn, Bonn, Germany.

Richard F Spaide (RF)

Vitreous Retina Macula Consultants of New York, New York, New York, USA.

SriniVas Sadda (S)

Doheny Image Reading Center, Doheny Eye Institute, Los Angeles, California, USA.

David Sarraf (D)

Retinal Disorders and Ophthalmic Genetics Division, Stein Eye Institute, University of California, Los Angeles, Los Angeles, California, USA dsarraf@ucla.edu.
Greater Los Angeles Veterans Affairs Healthcare Center, Los Angeles, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH